期刊文献+

雷尼替丁枸橼酸铋联用克拉霉素治疗十二指肠溃疡的临床疗效

Ranitidine Bismuth Citrate,Clarithromycin to Unite and is Studied with the Clinical Curative Effect of Treating the Duodenal Ulcer
在线阅读 下载PDF
导出
摘要 目的观察雷尼替丁枸橼酸铋联用克拉霉素治疗治疗十二指肠溃疡的疗效。方法选择128例活动性十二指肠溃疡患者,随机分治疗组64例与对照组64例进行比较。结果治疗4周后治疗组总有效率为92.76%,优于对照组80.3%,差异有显著性意义(P<0.05)。结论雷尼替丁枸橼酸铋联用克拉霉素治疗十二指肠溃疡的疗效好,副作用小。 Objective to ranitidine bismuth citrate,clarithromycin curative effect of treating the duodenal ulcer. Methods Choose 128 activity duodenal ulcer patients, is divided into and treat 64groups to compare with contrast group 64 at random.Results It is 91.2% that it is always efficient to treat the group after treating for 4 weeks, superior to the 92.76% of group of contrast , there are remarkable meanings in the difference(P<0.05).Conclusion It is good that ranitidine bismuth citrate,clarithromycin curative effect of treating the duodenal ulcer, The side effect is small.
出处 《中国实用医药》 2006年第5期18-19,共2页 China Practical Medicine
关键词 雷尼替丁枸橼酸铋 克拉霉素 指肠溃疡 ranitidine bismuth citrate clarithromycin Duodenalulcer
  • 相关文献

参考文献6

二级参考文献15

  • 1王玉刚,茹倩影.具有细胞毒素相关蛋白和细胞空泡毒素的幽门螺杆菌与消化性溃疡的相关性研究[J].上海预防医学,1999,11(2):58-59. 被引量:1
  • 2[1]Stables R, Campbell CJ, Clayton NM, et al. Gastric anti-secretory, mucosal protective, anti-Helicobacter properties of ranitidine bismuth citrae. Aliment Pharmacol Ther,1993;7:237~246.
  • 3[2]Lacey LF, Frazer NM, Keene ON, et al. Comparative pharmacokinetics of bismuth from ranitidine bismuth citrate (GR122311X) , a novel anti-ulcerant and tripotassium dicitrato bismuthate(TDB). Eur J Pharmacol, 1994;47:177~180.
  • 4[3]Bardhan KD, Dekkers CP , Lam SK, et al. GR122311X(ranitidine bismuth citrate), a new drug for the treatment of duodenal ulcer. Aliment Pharmacol Ther, 1995;9:497~506.
  • 5[4]Laine L, Estrada R, Trujillo M, et al. Randomized comparison of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori. Am J Gastroenterol, 1997;92:2213~2215.
  • 6[5]Van der Wouden EJ, Thijs JC, van Zwet AA, et al. One week triple therapy with ranitidine bismuth citrate, clarithromycine and metronidazole versus two-week dual therapy with ranitidine bismuth citrate and clarithromycine for Helicobacter pylori infection: a randomized, clinical trial. Am J Gastroenterol, 1998, 93:1228~1231.
  • 7[6]Spadaccini A, De Fanis C, Sciampa G, et al. Triple regimens using lansoprazole or ranitidine bismuth citrate for Helicobacter pylori eradication. Aliment Pharmacol Ther, 1998;12:997~1001.
  • 8[7]Gasbarrini A, Ojetti V, Armuzzi A, et al. Efficacy of a multistep strategy for Helicobacter pylori eradication. Aliment Pharmacol Ther, 2000;14:79~83.
  • 9[8]Spinzi GC, Boni F, Bortoli A, et al. Seven-day triple therapy with ranitidine bismuth citrate or omeprazole and two antibiotics for eradication of Helicobacter pylori in duodenal ulcer: a multicentre, randomized, single-blind study. Aliment Pharmacol Ther, 2000;14: 325~330.
  • 10[9]Kung NN, Sung JJ, Yuen NW, et al. One week ranitidine bismuth citrate versus colloidal subcitrate based anti-Helicobacter tripletherapy: a prospective randomized controlled trial. Am J Gastroenterol, 1999;94:721~724.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部